EP3565573 - PAC1 RECEPTOR AGONISTS (MAXCAPS) AND USES THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 27.06.2024 Database last updated on 03.09.2024 | |
Former | The patent has been granted Status updated on 21.07.2023 | ||
Former | Grant of patent is intended Status updated on 13.03.2023 | ||
Former | Examination is in progress Status updated on 01.07.2021 | ||
Former | Request for examination was made Status updated on 11.10.2019 | ||
Former | The international publication has been made Status updated on 13.07.2018 | Most recent event Tooltip | 30.08.2024 | Lapse of the patent in a contracting state New state(s): MC | published on 02.10.2024 [2024/40] | Applicant(s) | For all designated states The Regents of the University of California 1111 Franklin Street, 12th Floor Oakland, CA 94607 / US | For all designated states The United States Government Represented by the Department of Veterans Affairs Office of the General Counsel Washington, DC 20420 / US | [2019/46] | Inventor(s) | 01 /
PISEGNA, Joseph R. 834 26th Street Santa Monica, California 90403 / US | 02 /
GERMANO, Patrizia M. 834 26th Street Santa Monica, California 90403 / US | 03 /
VU, John P. 111 Franklin St., 12th Fl. Oakland, CA 94607-5200 / US | [2019/47] |
Former [2019/46] | 01 /
PISEGNA, Joseph R. 834 26th Street Santa Monica, California 90403 / US | ||
02 /
GERMANO, Patrizia M. 834 26th Street Santa Monica, California 90403 / US | |||
03 /
VU, John P. 1437 S. Westgate Avenue, 4 Los Angeles, California 90025 / US | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [2023/34] |
Former [2019/46] | Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | Application number, filing date | 18736163.9 | 04.01.2018 | [2019/46] | WO2018US12405 | Priority number, date | US201762442906P | 05.01.2017 Original published format: US 201762442906 P | [2019/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2018129200 | Date: | 12.07.2018 | Language: | EN | [2018/28] | Type: | A2 Application without search report | No.: | EP3565573 | Date: | 13.11.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.07.2018 takes the place of the publication of the European patent application. | [2019/46] | Type: | B1 Patent specification | No.: | EP3565573 | Date: | 23.08.2023 | Language: | EN | [2023/34] | Search report(s) | International search report - published on: | US | 09.08.2018 | (Supplementary) European search report - dispatched on: | EP | 10.07.2020 | Classification | IPC: | A61K38/00, C07K14/435, C07K19/00, A61P1/16, A61P3/04, A61P3/10, C07K14/575, C07K14/705, // A61K38/22 | [2020/33] | CPC: |
C07K14/70503 (EP);
C07K14/57563 (EP,US);
A61K31/4985 (US);
A61K38/2278 (US);
A61K47/60 (US);
A61K47/61 (US);
A61K47/65 (US);
A61P1/16 (EP);
A61P3/04 (EP);
A61P3/10 (EP);
C07K14/43577 (EP,US);
A61K38/00 (EP,US);
C07K2319/00 (EP,US)
(-)
|
Former IPC [2019/46] | A61K38/00, C07K14/435, C07K19/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/46] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | PAC1-REZEPTOR-AGONISTEN (MAXCAPS) UND VERWENDUNGEN DAVON | [2019/46] | English: | PAC1 RECEPTOR AGONISTS (MAXCAPS) AND USES THEREOF | [2019/46] | French: | AGONISTES DU RÉCEPTEUR PAC1 (MAXCAPS) ET LEURS UTILISATIONS | [2019/46] | Entry into regional phase | 02.07.2019 | National basic fee paid | 02.07.2019 | Search fee paid | 02.07.2019 | Designation fee(s) paid | 02.07.2019 | Examination fee paid | Examination procedure | 02.07.2019 | Examination requested [2019/46] | 04.02.2021 | Amendment by applicant (claims and/or description) | 30.06.2021 | Despatch of a communication from the examining division (Time limit: M06) | 07.12.2021 | Reply to a communication from the examining division | 13.03.2023 | Communication of intention to grant the patent | 17.07.2023 | Fee for grant paid | 17.07.2023 | Fee for publishing/printing paid | 17.07.2023 | Receipt of the translation of the claim(s) | Opposition(s) | 24.05.2024 | No opposition filed within time limit [2024/31] | Fees paid | Renewal fee | 27.01.2020 | Renewal fee patent year 03 | 27.01.2021 | Renewal fee patent year 04 | 27.01.2022 | Renewal fee patent year 05 | 27.01.2023 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 23.08.2023 | CZ | 23.08.2023 | DK | 23.08.2023 | EE | 23.08.2023 | ES | 23.08.2023 | FI | 23.08.2023 | HR | 23.08.2023 | LT | 23.08.2023 | LV | 23.08.2023 | MC | 23.08.2023 | NL | 23.08.2023 | PL | 23.08.2023 | RO | 23.08.2023 | RS | 23.08.2023 | SI | 23.08.2023 | SK | 23.08.2023 | SM | 23.08.2023 | NO | 23.11.2023 | GR | 24.11.2023 | IS | 23.12.2023 | PT | 26.12.2023 | [2024/40] |
Former [2024/36] | AT | 23.08.2023 | |
CZ | 23.08.2023 | ||
DK | 23.08.2023 | ||
EE | 23.08.2023 | ||
ES | 23.08.2023 | ||
FI | 23.08.2023 | ||
HR | 23.08.2023 | ||
LT | 23.08.2023 | ||
LV | 23.08.2023 | ||
NL | 23.08.2023 | ||
PL | 23.08.2023 | ||
RO | 23.08.2023 | ||
RS | 23.08.2023 | ||
SI | 23.08.2023 | ||
SK | 23.08.2023 | ||
SM | 23.08.2023 | ||
NO | 23.11.2023 | ||
GR | 24.11.2023 | ||
IS | 23.12.2023 | ||
PT | 26.12.2023 | ||
Former [2024/23] | AT | 23.08.2023 | |
CZ | 23.08.2023 | ||
DK | 23.08.2023 | ||
EE | 23.08.2023 | ||
ES | 23.08.2023 | ||
FI | 23.08.2023 | ||
HR | 23.08.2023 | ||
LT | 23.08.2023 | ||
LV | 23.08.2023 | ||
NL | 23.08.2023 | ||
PL | 23.08.2023 | ||
RO | 23.08.2023 | ||
RS | 23.08.2023 | ||
SK | 23.08.2023 | ||
SM | 23.08.2023 | ||
NO | 23.11.2023 | ||
GR | 24.11.2023 | ||
IS | 23.12.2023 | ||
PT | 26.12.2023 | ||
Former [2024/22] | AT | 23.08.2023 | |
CZ | 23.08.2023 | ||
DK | 23.08.2023 | ||
FI | 23.08.2023 | ||
HR | 23.08.2023 | ||
LT | 23.08.2023 | ||
LV | 23.08.2023 | ||
NL | 23.08.2023 | ||
PL | 23.08.2023 | ||
RO | 23.08.2023 | ||
RS | 23.08.2023 | ||
SM | 23.08.2023 | ||
NO | 23.11.2023 | ||
GR | 24.11.2023 | ||
IS | 23.12.2023 | ||
PT | 26.12.2023 | ||
Former [2024/20] | AT | 23.08.2023 | |
FI | 23.08.2023 | ||
HR | 23.08.2023 | ||
LT | 23.08.2023 | ||
LV | 23.08.2023 | ||
NL | 23.08.2023 | ||
PL | 23.08.2023 | ||
RS | 23.08.2023 | ||
SM | 23.08.2023 | ||
NO | 23.11.2023 | ||
GR | 24.11.2023 | ||
IS | 23.12.2023 | ||
PT | 26.12.2023 | ||
Former [2024/10] | AT | 23.08.2023 | |
FI | 23.08.2023 | ||
HR | 23.08.2023 | ||
LT | 23.08.2023 | ||
LV | 23.08.2023 | ||
NL | 23.08.2023 | ||
PL | 23.08.2023 | ||
RS | 23.08.2023 | ||
NO | 23.11.2023 | ||
GR | 24.11.2023 | ||
IS | 23.12.2023 | ||
PT | 26.12.2023 | ||
Former [2024/09] | AT | 23.08.2023 | |
FI | 23.08.2023 | ||
LT | 23.08.2023 | ||
NL | 23.08.2023 | ||
NO | 23.11.2023 | ||
GR | 24.11.2023 | ||
IS | 23.12.2023 | ||
Former [2024/08] | LT | 23.08.2023 | |
NL | 23.08.2023 | ||
NO | 23.11.2023 | ||
GR | 24.11.2023 | Documents cited: | Search | [XI]US5480864 (TAJIMA MASAHIRO [JP], et al); | [XI]WO0185100 (GEN HOSPITAL CORP [US], et al); | [XI]US2002182729 (DICICCO-BLOOM EMANUEL [US], et al); | [XI]US2004038888 (MERCER ALEX [SE], et al); | [A]US2015104388 (COY DAVID H [US], et al); | International search | [A]US5480864 (TAJIMA MASAHIRO [JP], et al); | [A]WO0185100 (GEN HOSPITAL CORP [US], et al); | [A]US2002182729 (DICICCO-BLOOM EMANUEL [US], et al); | [A]US2004038888 (MERCER ALEX [SE], et al); | [A]US2015104388 (COY DAVID H [US], et al); | by applicant | US4414148 | US4496542 | US4569789 | US4589071 | EP0188256 | US4659839 | US4671958 | US4680338 | US4699784 | US5152923 | US5480864 | US5698219 | US5753241 | US5925341 | US6039936 | US6120778 | WO0059863 | US6274150 | WO0185100 | US6335022 | US6375960 | US6413527 | US6419946 | US6461625 | US6464990 | US2002182729 | US6541018 | US6689371 | US2004038888 | US6902737 | US6998426 | US7314624 | US7476393 | US2015104388 |